Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NaBen as Add-on to Clozapine for Refractory Schizophrenia
NCT03094429Phase 3Recruiting
- Sponsor
- SyneuRx
- Start
- Mar 2017
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium benzoate in schizophrenia, sponsored by SyneuRx. Started Mar 2017; status: recruiting.
02
Drugs
sodium benzoate
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03094429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03094429.